ロード中...

Real-World Use – Isavuconazole at a Large Academic Medical Center

BACKGROUND: Invasive fungal infections cause significant mortality and morbidity. Isavuconazole (ISV) is a new triazole approved for treatment of mucormycosis and aspergillosis. Data on its effectiveness outside clinical trials and in patients receiving prior triazole prophylaxis are lacking. METHOD...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Hassouna, HabiBA, Brizendine, Kyle, Athans, Vasilios
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631743/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.028
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!